Comment: Delayed wound healing with sirolimus after liver transplant [3]

Annals of Pharmacotherapy

Volumn 37, Issue 3, 2003, Pages 453-

  Mathis, Scott ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; RAPAMYCIN; TACROLIMUS;

ARTERY THROMBOSIS; GRAFT REJECTION; HUMAN; LETTER; LIVER TRANSPLANTATION; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; WOUND DEHISCENCE; WOUND HEALING;

CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; SIROLIMUS; SURGICAL WOUND DEHISCENCE; TACROLIMUS;

EID: 0347478141     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A128a     Document Type: Letter

References (4)

1. Guilbeau JM. Delayed wound healing with sirolimus after liver transplant. Ann Pharmacother 2002;36:1391-5.
2. Dagher F, John D, Morgan GR, Diflo T, Wehbe M, Hyman K, et al. Sirolimus impairs wound healing in an animal model (abstract). Am J Transplant 2001;1(suppl 1):222.
3. Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. Lancet 2000;356:194-202.
4. Package insert. Rapamune (sirolimus). Philadelphia: Wyeth Laboratoties, September 2002.